跳至主要内容
临床试验/IRCT20220211053995N1
IRCT20220211053995N1招募中2 期

The effect of Botulinum toxin type A on reducing sialorrhea in patients with cerebral palsy in Akbar Children's Hospital

Mashhad University of Medical Sciences0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
4 years 至 16 years(—)
性别
All

入选标准

  • patients with cerebral palsy
  • Drooling frequency scale 4 and severity and Teacher scale more than 4
  • Age between 4 and 16 years
  • Consent of parents or legal guardians to enter the study

排除标准

  • Contraindications of botulinum toxin A injection such as myasthenia gravis and Eaton-Lambert syndrome
  • Botulinum toxin A injection for at least the last four months
  • Receiving systemic medication to treat sialorrhea in the last three months
  • Recent maxillofacial surgery that may interfere with saliva production and flow.

研究者

相似试验

Unknown
早期 1 期
"Efficacy of Botulinum Toxin Injection in Reducing Limb Pain in Patients With Complex Regional Pain Syndrome"Complex Regional Pain Syndrome
NCT03616262VA Connecticut Healthcare System20
招募中
3 期
Evaluation the effect of Botulinium toxin injection on improving symptoms in patients with diabetic neuropathy
IRCT20240116060710N1Shahid Beheshti University of Medical Sciences30
已完成
不适用
comparison of the effect of botulinium toxin A injection with placebo in reducing the pain of patients with myofacial paitemporomandibular disorder.Temporomandibular joint disorders
IRCT2016051527894N2Vice chancellor for research of Ahvaz Jundishapur University of Medical Sciences34
已完成
2 期
Assessment of the botulinum toxin type A effect on Intensified Raynauds Phenomenon in Sclerodermic patientsSystemic sclerosis [scleroderma].Systemic sclerosis [scleroderma]
IRCT20200106046023N1Oroumia University of Medical Sciences11
进行中(未招募)
不适用
The efficacy of the Botulinum toxin-A on the manual abilities in children with congenital spastic hemiplegia. Interest of the measure of the bimanual task performance.The main objective of this study is to investigate the effect of Botulinum toxin A to improve the Upper Limb dysfunction in Hemiplegic Cerebral Palsy Children and in particular, its impact on Upper limb activity performance and how this might be translate in bimanual activities.MedDRA version: 12.0Level: LLTClassification code 10019475Term: Hemiplegic infantile cerebral palsy
EUCTR2009-015620-29-BE30